Cite
HARVARD Citation
Skarbnik, A. et al. (2017). Treatment patterns and outcomes with subcutaneous bortezomib in patients with relapsed mantle cell lymphoma: a retrospective, observational study of patient medical records from US community oncology practices. Leukemia & lymphoma. 58 (8), pp. 1968-1972. [Online].